Blue Trust Inc’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.2K Buy
675
+31
+5% +$977 ﹤0.01% 1620
2025
Q4
$19K Buy
644
+52
+9% +$1.45K ﹤0.01% 1703
2025
Q3
$14.9K Buy
592
+12
+2% +$292 ﹤0.01% 1752
2025
Q2
$13.9K Buy
580
+86
+17% +$1.99K ﹤0.01% 1797
2025
Q1
$11.3K Sell
494
-22
-4% -$531 ﹤0.01% 1843
2024
Q4
$13.1K Sell
516
-483
-48% -$12.2K ﹤0.01% 1737
2024
Q3
$29.6K Buy
999
+347
+53% +$10.3K ﹤0.01% 1788
2024
Q2
$19.7K Buy
652
+541
+487% +$15K ﹤0.01% 1664
2024
Q1
$3.35K Sell
111
-171
-61% -$4.75K ﹤0.01% 1711
2023
Q4
$10K Buy
282
+119
+73% +$3.5K ﹤0.01% 1592
2023
Q3
$6K Buy
163
+87
+114% +$3.32K ﹤0.01% 1599
2023
Q2
$2K Sell
76
-100
-57% -$3.92K ﹤0.01% 1751
2023
Q1
$6K Buy
+176
New +$5.55K ﹤0.01% 1755

Other funds holding RTO

Blue Trust Inc's RTO Position: Q1 2026 in Review

Blue Trust Inc increased its Rentokil (RTO) stake by 4.8% in Q1 2026, buying an estimated $977 and bringing the position to 675 shares worth $21.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1620.

Blue Trust Inc first reported a position in RTO in Q1 2023 and has held it in 13 quarters since. The position peaked at $29.6K in Q3 2024. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • Blue Trust Inc held 675 shares of Rentokil worth $21.2K as of Q1 2026.
  • Blue Trust Inc bought 31 Rentokil shares in Q1 2026, an estimated $977.
  • Rentokil made up ﹤0.01% of Blue Trust Inc's portfolio in Q1 2026, its #1620 holding.
  • Blue Trust Inc first reported a position in Rentokil in Q1 2023 and has held it in 13 quarters since.
  • Blue Trust Inc's Rentokil position peaked at $29.6K in Q3 2024.
  • 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Blue Trust Inc's 13F filing for Q1 2026, filed 20 Apr 2026.